Pharmaceutical and biotech companies will buy our algorithm, DeepPath, because it improves their computational aided drug design efforts.

Industry

Healthcare & Lifesciences

Market Segment

Academia/Education
B2B
B2B2C

Technology

AI/ML/CV/Generative AI
Chemical/Chemistry/Materials
Cloud computing
Pharma/Diagnostic/Biochem
Software-Licensed/Integrated
Katie Kuo
JC Gumbart
Andrew Pang
Portfolio

Company Email Address

kmkuo@gatech.edu